Recently, Dobot CR series collaborative robots have been officially put into use at the Vivantes laboratory of Labor Berlin, the largest clinical laboratory in Europe. The successful implementation of this project further proves the overseas recognition of the strength and quality of Dobot robotic products by authoritative institutions.
Established in 2011, Labor Berlin is home to the largest hospital laboratory in Europe, and is a leading authority in ten major medical testing fields including genetics, immunology, hematology, and oncology.
It is understood that this is the first time Labor Berlin has introduced collaborative robots into medical laboratories. Labor Berlin has specially named the three CR series collaborative robots: Friedrich, Haini, and Haino. They stated that in the initial phase, the robots will be responsible for tasks such as sample collection, centrifugation, chemical processing, and sample archiving, and will be applied to more scenarios in the future.
Labor Berlin believes that the introduction of collaborative robots will help free their staff from repetitive and mundane tasks, allowing them to focus more on evaluating results or handling special samples such as premature infant samples, thereby enhancing the overall efficiency of the laboratory's operation.
For medical testing, the precision, cleanliness, and reliability of collaborative robots are particularly crucial. The successful implementation of this project signifies that Dobot collaborative robots have once again gained recognition from overseas authoritative institutions for their strength and quality. A foreign industry practitioner commented in a related report, "Fantastic! Given the current shortage of technical workers, this is an important step towards the future!"
Fantastisch! ... Ein bedeutender Schritt in die Zukunft angesichts des aktuellen Fachkräftemangels!
In recent years, Dobot Robotics has actively expanded into overseas markets, establishing branches in Germany, Japan, the United States, and other locations, with a global cumulative shipment of over 68,000 units. Dobot has consistently adhered to independent research and development of core technologies, significantly reducing the barriers to use and costs of robots through innovative human-machine interaction technologies, thereby promoting the widespread application of robots in more fields beyond industrial settings. In the future, Dobot will continue to drive its "going global" strategy, providing strong impetus for the global upgrade of intelligent manufacturing.